CD274 and neuroblastoma: Syngenic PD-L1+/GD2+ NB-bearing mice treated with ch14.18/CHO combined with anti-PD-1 mAb showed a strong reduction of tumor growth, prolonged survival, and the highest cytotoxicity against NB cells.